Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME Heparan sulfate hydrolytic enzyme DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Mucopolysaccharidoses 3 D009083 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
16.98
Respiratory, thoracic and mediastinal disorders
16.48
Infections and infestations
8.44
Nervous system disorders
7.59
Injury, poisoning and procedural complications
7.48
Immune system disorders
6.46
Skin and subcutaneous tissue disorders
5.52
Cardiac disorders
4.86
Gastrointestinal disorders
4.69
Vascular disorders
4.23
Psychiatric disorders
3.43
Musculoskeletal and connective tissue disorders
2.9
Metabolism and nutrition disorders
2.28
Investigations
2.02

Cross References

Resources Reference
CAS NUMBER 50936-59-9
ChEMBL CHEMBL1201826
FDA SRS 5W8JGG2651